These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 28101958)

  • 21. Maternal anti-D prophylaxis during pregnancy does not cause neonatal haemolysis.
    Maayan-Metzger A; Schwartz T; Sulkes J; Merlob P
    Arch Dis Child Fetal Neonatal Ed; 2001 Jan; 84(1):F60-2. PubMed ID: 11124929
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Causes and clinical consequences of Rhesus (D) haemolytic disease of the newborn: a study of a Scottish population, 1985-1990.
    Hughes RG; Craig JI; Murphy WG; Greer IA
    Br J Obstet Gynaecol; 1994 Apr; 101(4):297-300. PubMed ID: 8199074
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Red blood cell iso-immunisation in the Wellington area of New Zealand: the case for antenatal prophylaxis.
    Tuohy JF; Sangalli M; Kim L
    Aust N Z J Obstet Gynaecol; 2004 Oct; 44(5):458-9. PubMed ID: 15387870
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Severe anti-D haemolytic disease of fetal and newborn in rhesus D negative primigravida.
    Hassan MZ; Iberahim S; Abdul Rahman WSW; Zulkafli Z; Bahar R; Ramli M; Mohd Noor NH; Mustaffa R
    Malays J Pathol; 2019 Apr; 41(1):55-58. PubMed ID: 31025639
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [New recommendations for the completion of rhesus-immunization prophylaxis with anti-D].
    Maas DH; Schneider J
    Immun Infekt; 1982 Nov; 10(6):244-9. PubMed ID: 6307863
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Routine antenatal anti-D prophylaxis and patient compliance with the two-dose regimen.
    Chaffe B; Ford J; Bills V
    Transfus Med; 2007 Oct; 17(5):399-403. PubMed ID: 17903141
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Third trimester screening for alloimmunisation in Rhc-negative pregnant women: evaluation of the Dutch national screening programme.
    Slootweg YM; Koelewijn JM; van Kamp IL; van der Bom JG; Oepkes D; de Haas M
    BJOG; 2016 May; 123(6):955-63. PubMed ID: 26661943
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The clinical outcome of non-RhD antibody affected pregnancies in Northern Ireland.
    Chandrasekar A; Morris KG; Tubman TR; Tharma S; McClelland WM
    Ulster Med J; 2001 Nov; 70(2):89-94. PubMed ID: 11795772
    [TBL] [Abstract][Full Text] [Related]  

  • 29. On the immunologic basis of Rh immune globulin (anti-D) prophylaxis.
    Kumpel BM
    Transfusion; 2006 Sep; 46(9):1652-6. PubMed ID: 16965599
    [No Abstract]   [Full Text] [Related]  

  • 30. [Prenatal immunoglobulin prevention in Rh(D)-negative nonsensitized pregnant women].
    Katsulov A
    Akush Ginekol (Sofiia); 1997; 36(2):1-2. PubMed ID: 9471891
    [No Abstract]   [Full Text] [Related]  

  • 31. [Prevention of fetomaternal rhesus-D allo-immunization. Practical aspects].
    Cortey A; Brossard Y
    J Gynecol Obstet Biol Reprod (Paris); 2006 Feb; 35(1 Suppl):1S123-1S130. PubMed ID: 16495838
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The use of anti-D immunoglobulins for rhesus prophylaxis: audit on knowledge and practices among obstetricians.
    Wee WW; Kanagalingam D
    Singapore Med J; 2009 Nov; 50(11):1054-7. PubMed ID: 19960158
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Red-cell and platelet alloimmunisation in pregnancy.
    Egbor M; Knott P; Bhide A
    Best Pract Res Clin Obstet Gynaecol; 2012 Feb; 26(1):119-32. PubMed ID: 22119066
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The use of anti-D prophylaxis in the management of miscarriage in general practice.
    Roberts H; Mitchell R
    Health Bull (Edinb); 1991 Jul; 49(4):245-9. PubMed ID: 1657828
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Has anti-D prophylaxis increased the rate of positive direct antiglobulin test results and can the direct antiglobulin test predict need for phototherapy in Rh/ABO incompatibility?
    Dillon A; Chaudhari T; Crispin P; Shadbolt B; Kent A
    J Paediatr Child Health; 2011 Jan; 47(1-2):40-3. PubMed ID: 20973864
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The economics of routine antenatal anti-D prophylaxis for pregnant women who are rhesus negative.
    Chilcott J; Tappenden P; Lloyd Jones M; Wight J; Forman K; Wray J; Beverley C
    BJOG; 2004 Sep; 111(9):903-7. PubMed ID: 15327602
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Recommendations for clinical practice. Prevention in maternofetal Rh immunization (December 2005)].
    Collège National des Gynécologues et Obstétriciens Français
    Gynecol Obstet Fertil; 2006 Apr; 34(4):360-5. PubMed ID: 16644259
    [No Abstract]   [Full Text] [Related]  

  • 38. RhD negative women. Are we ready to change practice?
    Wray J
    Pract Midwife; 2000 Oct; 3(9):26-8. PubMed ID: 12026547
    [No Abstract]   [Full Text] [Related]  

  • 39. [Advantages of preventing Rh isoimmunization].
    Mikulandra F; Merlak I; Perisa M; Kapitanović Z; Barbetti V; Kimer M; Glavadanović N
    Jugosl Ginekol Perinatol; 1985; 25(1-2):29-34. PubMed ID: 3003466
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Adverse effects and patient information].
    Cortey A; Brossard Y
    J Gynecol Obstet Biol Reprod (Paris); 2006 Feb; 35(1 Suppl):1S112-1S118. PubMed ID: 16495836
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.